“The depleted franking credit balance is a lag effect of the costs of transforming our business. Our underlying business is performing strongly, with FY20 financial results remaining on track. More importantly, we continue to expect accelerated underlying earnings growth in FY21 from our core business.”
Sigma, which is also the owner of Australian pharmacy retail brands Amcal Max, DDS, Amcal and Guardian, is on the hunt for a new chief financial officer after Iona MacPherson suddenly left amid the restructduring.
Mr Hooper said in early January the timing of the CFO change “is not ideal”, and that it wouldn’t have any impact on the company’s trading performance or the achievement of its $100 million efficiency gains previously outlined in its transformation program.
Mr Hooper plans to give guidance for financial 2021 at the full year results announcement scheduled on March 25.
